Publications by authors named "Zulpikar Abdulla"
Article Synopsis
- The study explored long-term outcomes for patients with locally advanced gastric cancer who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC).
- The analysis included 37 patients, revealing 3- and 5-year overall survival rates of 88.8% and 78.6%, and progression-free survival rates of 86.5% and 75.8%.
- Factors like receiving more than 3 cycles of NAC and poorly differentiated tumors at diagnosis were identified as protective for overall survival, while NAC duration was the main factor for progression-free survival.
Background: The prognosis of unresectable gastric cancer is poor, while the efficacy of anti-PD antibodies has not been evaluated.
Methods: Patients with unresectable gastric cancer who received intra-arterial chemotherapy (IAC) with sequential anti-PD-1 antibody as induction therapy in Jinling Hospital were retrospectively analyzed. The primary outcome is R0 resection rate.